Abstract
Background
The choice of first-stage operation in bilio-pancreatic diversion with duodenal switch (BPD-DS) is controversial. There are no published long-term comparisons of one- and two-stage BPD-DS outcomes.
Methods
During 2001–2009, among 1,762 patients scheduled for BPD-DS 48 had duodenal switch (DS) and 53 sleeve gastrectomy (SG) as first-stage procedures. We compared prospectively updated outcomes of 42 DS (100 % open) and 49 SG (88 % laparoscopic), 13 of whom completed their second stage, to a control group of 91 patients with open one-stage BPD-DS.
Results
One-year mean percent excess weight loss (%EWL) was greater after SG than DS (47 ± 19 vs. 39 ± 13 SD; p = 0.01) with earlier nadir (16 ± 10 vs. 45 ± 30 months; p < 0.0001) but more rapid significant weight regain. After 5 years, %EWL was 12 ± 35 for 9 SG, 45 ± 19 for 30 DS (p < 0.0006), and 70 ± 18 for the first-stage BPD-DS (p < 0.0001). Weight loss was less after two- than one-stage procedures (p < 0.02). Comorbidities improved progressively between SG, DS and BPD-DS (p < 0.001 for trend). HbA1C decreased by 10, 19, and 31 %, respectively (p < 0.0001). Dyslipidemia was cured in 41, 82, and 100 %, respectively. Systolic and diastolic blood pressure decreased only after DS (12 %; p < 0.0002). Patient satisfaction was similar for SG and DS but greater after BPD-DS overall (p = 0.04).
Conclusions
SG and DS independently contribute to beneficial metabolic outcomes after BPD-DS. Long-term weight loss and correction of metabolic abnormalities were better after DS favoring its use as first stage in BPD-DS; one-stage BPD-DS outcomes were superior to two-staged.
Similar content being viewed by others
References
Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66:618–20.
Scopinaro N, Gianetta E, Civalleri D, et al. Biliopancreatic bypass for obesity. An experimental study in dogs. Br J Surg. 1979;66:613–7.
Sarson D, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPD) bypass surgery for morbid obesity. Int J Obes. 1981;5:471–80.
Adami GF, Campostano A, Bissarione D, et al. Resting energy expenditure in long-term post obese subjects after weight normalisation by dieting or biliopancreatic diversion. Obes Surg. 1993;3:397–9.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.
Scopinaro N, Marinari M, Camerini G, et al. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000;10:436–41.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.
Marceau P, Biron S, Bourque RA, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3:29–35.
Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.
Ren JC, Patterson E, Gagner M. Early Results of Laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514–23.
Regan JP, Inabnet WB, Gagner M, et al. Early experience with two stage laparoscopic Roux-en-y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.
Gagner M, Chu C, Quinn T et al. Two-stage laparoscopic diversion with duodenal switch: an alternative approach to super-super morbid obesity. Surg Endosc. 2003.
Moy J, Pomp A, Dakin G, et al. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg. 2008;196:e56–9.
Deitel M, Crosby RD, Gagner M. The first International Consensus Summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008; 487-96.
ASBS Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2010; 6: 1-5.
Rosenthal RJ. International Sleeve Gastrectomy Expert Panel consensus statement best practice guidelines. Surg Obes Relat Dis. 2012;8:8–19.
Marceau P, Biron S, Hould FS, et al. Obesity surgery principles and practice. In: Pitombo C, Jones K, Higa K, Pariza J, editors. Malabsorptiveprocedures: duodenal switch; Chapitre 14. New York: McGraw-Hill; 2008. p. 131–6.
Deitel M. Surgery for the morbidly obese patients. 1998 FD Communication Inc., Toronto p.73-74.
Junquero D, Rival Y. Metabolic syndrome which definition for what treatment. Medicine/Sciences. 2005;21:1045–53.
Cossu ML, Noya G, Tonolo GC, et al. Duodenal switch without gastric resection: results and observation after 6 years. Obes Surg. 2004;14:1354–9.
Himpens J, Dobbeleir J, Peeters G. Long -term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319–24.
Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535–40.
Sarela AI, Dexter SP, O’kane M, et al. Long-term follow up after laparoscopic sleeve gastrectomy: 8–9 years results. Surg Obes Relat Dis. 2012;8:679–84.
Kehagias I, Spyropoulos C, Karamanakos S, et al. Efficacy of sleeve gastrectomy as sole procedure in patients with clinically severe obesity (BMI ≤50 kg/m2). Surg Obes Relat Dis. 2012;9(3):363–9.
Rawlins L, Rawlins MP, Brown CC, et al. Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis. 2013;9:21–5.
Diamantis T, Apostolou KG, Alexandrou A, et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10:177–83.
Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg. 2007;17:1297–305.
Garrido-Sanchez L, Murri M, Rivas-Becerra J, et al. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg Obes Relat Dis. 2012;8:145–50.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.
Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity. 2012;20:1266–72.
Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endoc Metab. 1999;84:1513–7.
Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135:48–57.
Buchwald H, Kellogg TA, Leslie DB, et al. Duodenal switch operative mortality and morbidly are not impacted by body mass index. Ann Surg. 2008;248:541–8.
Biertho L, Lebel S, Marceau S, et al. Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis. 2013;9:63–8.
Silecchia G, Rizzello M, Casella G, et al. Two-stage laparoscopic biliopancreatic diversion with duodenal switch as treatment of high-risk super-obese patients: analysis of complications. Surg Endosc. 2009;23:1032–7.
Iannelli A, Schneck AS, Topart P, et al. Laparoscopic sleeve gastrectomy followed by duodenal switch in selected patients versus single-stage duodenal switch for superobesity: case control study. Surg Obes Relat Dis. 2013;9:531–8.
Acknowledgments
We are grateful to Paule Marceau research Assistant and databank coordinator for her major contribution in the realization of this manuscript.
Disclosure
The authors have no commercial associations that might be a conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marceau, P., Biron, S., Marceau, S. et al. Biliopancreatic Diversion-Duodenal Switch: Independent Contributions of Sleeve Resection and Duodenal Exclusion. OBES SURG 24, 1843–1849 (2014). https://doi.org/10.1007/s11695-014-1284-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-014-1284-0